Need Help?
No Article Versions Notes Found
Cite
Duarte, F.A.; Ferreira, C.G.; Dienstmann, R.; Ferrari, B.L.; Costa E Silva, M.; Nazareth A. Junior, P.; Guilherme de O. Salles, P.; Henrique C. Diniz, P. Barriers in Precision Medicine Implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario. J. Mark. Access Health Policy 2022, 10, 2077905. https://doi.org/10.1080/20016689.2022.2077905
Duarte FA, Ferreira CG, Dienstmann R, Ferrari BL, Costa E Silva M, Nazareth A. Junior P, Guilherme de O. Salles P, Henrique C. Diniz P. Barriers in Precision Medicine Implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario. Journal of Market Access & Health Policy. 2022; 10(1):2077905. https://doi.org/10.1080/20016689.2022.2077905
Chicago/Turabian StyleDuarte, Flavia A., Carlos Gil Ferreira, Rodrigo Dienstmann, Bruno L. Ferrari, Matheus Costa E Silva, Pedro Nazareth A. Junior, Paulo Guilherme de O. Salles, and Paulo Henrique C. Diniz. 2022. "Barriers in Precision Medicine Implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario" Journal of Market Access & Health Policy 10, no. 1: 2077905. https://doi.org/10.1080/20016689.2022.2077905
APA StyleDuarte, F. A., Ferreira, C. G., Dienstmann, R., Ferrari, B. L., Costa E Silva, M., Nazareth A. Junior, P., Guilherme de O. Salles, P., & Henrique C. Diniz, P. (2022). Barriers in Precision Medicine Implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario. Journal of Market Access & Health Policy, 10(1), 2077905. https://doi.org/10.1080/20016689.2022.2077905
